If participants in the TGFβ signalling pathway increase, clinical conditions with excess angiogenesis can manifest, such as hereditary haemorrhagic telangiectasia (HHT) and Osler-Rendu-Weber syndrome, suggesting that TGFβ has a pro-angiogenic action [180]. Here, TGFB1 is linked to hereditary hemorrhagic telangiectasia.